Clinical Data
What is PREVYMIS?
PREVYMIS is an antiviral approved for CMV prophylaxis in adult CMV-seropositive recipients of allogeneic HSCT
A novel CMV DNA terminase complex inhibitor, PREVYMIS targets a component of the terminase complex involved in viral DNA cleavage and packaging, restricting drug activity to the virus alone.1